10 Unusual Stocks Attracting Huge Interest In The Pre-Market Right Now


Here’s where we see the heat today:

Adobe is getting annihilated, Research in Motion stages a comeback, bad news for Biogen, and more…

MICROSOFT BEGINS ITS ULTIMATE LIQUIDATION?: Dividend hiked by 23%, large debt issue announced, MSFT shares are falling

Nah, actually this might be good news despite the market reaction. Read about it here.

Adobe (ADBE) is being absolutely crushed by weak product demand concerns

PHARMA DISASTER: Vical (VICL) drug fails to prevent late-stage amputations, stock cratering

VENI, VEDI, VIVUS, AGAIN: Vivus (VVUS) continuing to rally even after yesterday's run

As a recap, they had received positive results on an obesity drug. Read about it here.

KEY DEAL: Origin Agritech (SEED) will have rights to a biotech crop innovation, shares soaring

DEAL: After falling earlier based on a buyback, Power-One (PWER) shares are now rallying


EARNINGS: General Mills (GIS) beats, but shares are down

BLACKPAD?: Can Research In Motion (RIMM) regain massive lost ground now that its iPad copy is rolling out?

Shares have picked up some steam. Read the WSJ's take on RIMM's new tablet here.

RAD DEAL: Radware (RDWR) announces a major deal in South Africa

WRONG GUIDANCE: PMC-Sierra (PMCS) diving after cutting its outlook

PHARMA CATALYST: Biogen Idec (BIIB) gets some bad news on the FDA front, shares tanking

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.